Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2018 February;59(1) > The Journal of Cardiovascular Surgery 2018 February;59(1):14-25

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

THE JOURNAL OF CARDIOVASCULAR SURGERY

A Journal on Cardiac, Vascular and Thoracic Surgery


Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,179


eTOC

 

REVIEW  DIAGNOSTICS AND TREATMENT MODALITIES FOR OBSTRUCTIVE AND ANEURYSMATIC ILIAC ARTERY DISEASE


The Journal of Cardiovascular Surgery 2018 February;59(1):14-25

DOI: 10.23736/S0021-9509.17.10213-2

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

The use of covered stents in aortoiliac obstructions: a systematic review and meta-analysis

Joost A. BEKKEN , Hidde JONGSMA, Bram FIOOLE

Department of Vascular Surgery, Maasstad Ziekenhuis, Rotterdam, The Netherlands


PDF  


INTRODUCTION: During the past decade, endovascular treatment has become the treatment of choice for all types of aortoiliac occlusive disease, including TASC C and D lesions. Patency rates, however, are still below those of open surgical techniques. One propagated technique to improve patency rates is the use of covered stents. This review assessed the available literature on covered stents for aortoiliac occlusive disease.
EVIDENCE ACQUISITION: An extensive search was performed of the MEDLINE, Embase, and Cochrane databases. All studies reporting on covered stents, including stent grafts for endovascular aneurysm repair, were included. A systematic review and meta-analysis was performed.
EVIDENCE SYNTHESIS: We identified 19 studies comprising 12 single-arm series, 6 retrospective series, and 1 randomized controlled trial. The meta-analysis did not show a significant difference in primary patency at 1, 2, and 3 to 5 years for covered stents compared with bare-metal stents (91.7% vs. 88.5%, 85.4% vs. 80.9%, and 80.7% vs. 72.0%, respectively). Several studies found a significant difference in TASC C and D lesions in favor of covered stents.
CONCLUSIONS: High-quality evidence supporting the use of covered stents for aortoiliac occlusive arterial disease is limited. The use of covered stents in TASC C and D lesions may improve patency rates. However, because the TASC classification is very heterogeneous, more research is needed to identify specifically which lesion characteristics might benefit most from covered stent placement.


KEY WORDS: Peripheral arterial disease - Iliac artery - Stents - Vascular patency

top of page

Publication History

Issue published online: November 28, 2017
Article first published online: September 20, 2017
Manuscript accepted: September 15, 2017
Manuscript received: September 8, 2017

Cite this article as

Bekken JA, Jongsma H, Fioole B. The use of covered stents in aortoiliac obstructions: a systematic review and meta-analysis. J Cardiovasc Surg 2018;59:14-25. DOI: 10.23736/S0021-9509.17.10213-2

Corresponding author e-mail

joostbekken@hotmail.com